Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Aeluma, Inc
Aeluma Announces First Quarter Fiscal 2026 Financial Results
Business
Nov 12 2025
10 min read

Aeluma Announces First Quarter Fiscal 2026 Financial Results

news images

Execution on Strategic Priorities Positions Aeluma for Future Growth

GOLETA, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a transformative semiconductor company specializing in high-performance and scalable technologies, today reported financial results for its first quarter of fiscal 2026 ended September 30, 2025.

Management Commentary

“We had another strong quarter executing on our strategic priorities including bolstering our balance sheet with a capital raise to accelerate growth, adding key talent throughout the organization, increasing our manufacturing readiness, and advancing towards commercialization,” said Jonathan Klamkin, Ph.D., Founder and CEO of Aeluma. “In this quarter, we also initiated a new contract with NASA, met several milestones for existing contracts, and made continued progress on customer engagements. The rapid acceleration of AI is driving unprecedented demand for optical component technologies, and we are uncovering greater opportunity aligned with our offerings and product roadmap. As we progress in fiscal 2026 with a solid financial position and positive trends in our target market verticals, our focus is on executing our go-to-market strategy to drive long-term shareholder value.”

Recent Company Highlights

  • Strong Financial Position: Closed fiscal Q1 2026 with $38 million in cash and no long-term debt.

  • New Contract with NASA: Executed one new R&D contract related to quantum. New contract to leverage Aeluma’s scalable semiconductor platform to provide a path to low size, weight and power quantum systems for space applications.

  • Increased Manufacturing Readiness: Increased outsourced wafer fabrication activities nearly five-fold. Acquired key equipment assets to increase in-house test and validation capacity for qualifying outsourced wafer production processes.

  • New Hires: Attracted highly experienced and accomplished professionals to fill key manufacturing and engineering positions including Director of Supply Chain Manufacturing and Director of Technology Enablement.

  • Intellectual Property: Recently filed two nonprovisional patent applications for core innovations. One relates to scalable, large-diameter wafer manufacturing for photonic components, and the other to large-format imaging sensors. Brings total issued and pending patents to 34.

Fiscal Q1 2026 Financial Results

  • Revenue was $1.4 million compared to $481 thousand in the first quarter of 2024, and $1.3 million in the fourth quarter of 2025. Revenue in the quarter was primarily from R&D contracts.

  • GAAP net loss was $1.5 million, or ($0.09) per basic and diluted share, compared to a net loss of $730 thousand, or ($0.06) per basic and diluted share, for the same period last year and net loss of $859 thousand, or ($0.05) per basic and diluted share, in the prior quarter.

  • GAAP net loss increased from the prior quarter primarily due to higher salaries, stock-based compensation and employee benefits driven by new employees hires to support the expansion of the business and scaling of operations.

  • Adjusted EBITDA loss was $450 thousand, compared to a loss of $457 thousand in the same period last year, and a loss of $113 thousand in the prior quarter.

  • Cash and cash equivalents totaled $38.1 million at September 30, 2025, compared to $15.7 million as of June 30, 2025.

Fiscal Year 2026 Guidance and Strategic Priorities

For the full fiscal year of 2026, based on current and anticipated market conditions, Aeluma continues to expect revenue in a range of $4.0 million to $6.0 million. The Company’s strategic priorities for 2026 include:

  • New Contract Wins: Three to seven new development contracts, which provide non-dilutive funding for R&D investments and the growth of partnership opportunities.

  • Team Expansion: Growth of our business development and go-to-market team, technical leadership and staff, and operations team.

  • Enhanced Manufacturing Readiness: Higher levels of outsourced wafer manufacturing productivity, expanded test and validation capabilities, technology qualification for targeted industries, and expanded supply chain partnerships.

  • Go-to-Market Traction: Continued progress on opportunities in target commercial markets and increasing the number of customer engagements in the pipeline. Immediate near-term focus on defense and aerospace, and photonics for AI infrastructure driving our product roadmap.

Conference Call and Webcast

Aeluma will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on November 12, 2025, to discuss the Company’s financial results and business outlook. Interested participants may access the conference the call by dialing (877) 317-6789 (domestic) or (412) 317-6789 (international) and referencing “Aeluma.”

A live webcast of the call will be available on the “Investors” section of Aeluma’s website and can also be accessed by clicking here. A replay of the conference call will be available on Aeluma’s website shortly after the call concludes.

Note about Non-GAAP Financial Measures

This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Aeluma believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company's financial condition and results of operations. Aeluma believes that these non-GAAP financial measures provide additional insight into Aeluma's ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Aeluma's results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation and amortization.

This press release includes non-GAAP financial measures, including:

  • Non-GAAP net income (loss), which is defined as GAAP net income (loss) plus stock-based compensation expenses, amortization of discount on convertible notes, and changes in fair value of derivative liabilities; and

  • Adjusted EBITDA, defined as non-GAAP net income (loss) plus depreciation and amortization expenses, less interest income.

A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company's expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

About Aeluma, Inc.

Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.

Company:

Aeluma, Inc.
(805) 351-2707
info@aeluma.com

Investor Contact:

Financial Profiles, Inc.
Moira Conlon & Tony Rossi
(310) 622-8221
ir@aeluma.com

 

Aeluma, Inc. and Subsidiary
Consolidated Balance Sheets

 

($ in thousands)

 

September 30,
2025
(unaudited)

 

 

June 30,
2025

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

25,920

 

 

$

3,628

 

Certificate of deposit

 

 

12,227

 

 

 

12,112

 

Accounts receivable

 

 

1,248

 

 

 

962

 

Deferred compensation

 

 

-

 

 

 

-

 

Prepaids and other current assets

 

 

829

 

 

 

633

 

Total current assets

 

 

40,224

 

 

 

17,335

 

Property and equipment:

 

 

 

 

 

 

 

 

Equipment

 

 

1,902

 

 

 

1,692

 

Leasehold improvements

 

 

547

 

 

 

547

 

Accumulated depreciation

 

 

(1,122

)

 

 

(1,021

)

Property and equipment, net

 

 

1,327

 

 

 

1,218

 

Right of use asset - operating

 

 

1,078

 

 

 

836

 

Other assets

 

 

24

 

 

 

17

 

Total assets

 

$

42,653

 

 

$

19,406

 

 

 

 

 

 

 

 

 

 

Liabilities and stockholders' equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

273

 

 

$

361

 

Accrued expenses and other current liabilities

 

 

306

 

 

 

206

 

Lease liability - operating, current portion

 

 

189

 

 

 

138

 

Derivative liabilities

 

 

-

 

 

 

-

 

Total current liabilities

 

 

768

 

 

 

705

 

Lease liability - operating, long-term portion

 

 

992

 

 

 

803

 

Convertible notes

 

 

-

 

 

 

-

 

Total liabilities

 

 

1,760

 

 

 

1,508

 

Commitments and contingencies

 

 

-

 

 

 

-

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock

 

 

-

 

 

 

-

 

Common stock

 

 

2

 

 

 

2

 

Additional paid-in capital

 

 

59,030

 

 

 

34,542

 

Accumulated deficit

 

 

(18,139

)

 

 

(16,646

)

Total stockholders’ equity

 

 

40,893

 

 

 

17,898

 

Total liabilities and stockholders’ equity

 

$

42,653

 

 

$

19,406

 



 

Aeluma, Inc. and Subsidiary
Consolidated Statements of Operations (unaudited)

 

 

 

Three Months Ended

 

($ in thousands, except per share data)

 

September 30,
2025

 

 

June 30,
2025

 

 

September 30,
2024

 

Revenue

 

$

1,385

 

 

$

1,317

 

 

$

481

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

701

 

 

 

779

 

 

 

315

 

Research and development

 

 

606

 

 

 

165

 

 

 

401

 

General and administrative

 

 

1,686

 

 

 

1,342

 

 

 

496

 

Total operating expenses

 

 

2,993

 

 

 

2,286

 

 

 

1,212

 

Loss from operations

 

 

(1,608

)

 

 

(969

)

 

 

(731

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

115

 

 

 

110

 

 

 

-

 

Amortization of discount on convertible notes

 

 

-

 

 

 

-

 

 

 

(145

)

Changes in fair value of derivative liabilities

 

 

-

 

 

 

-

 

 

 

146

 

Total other income, net

 

 

115

 

 

 

110

 

 

 

1

 

Loss before income tax expense

 

 

(1,493

)

 

 

(859

)

 

 

(730

)

Income tax expense

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

$

(1,493

)

 

$

(859

)

 

$

(730

)

Net loss per share – basic and diluted

 

$

(0.09

)

 

$

(0.05

)

 

$

(0.06

)

Weighted average common shares outstanding – basic and diluted

 

 

16,141,153

 

 

 

15,824,222

 

 

 

12,178,424

 

Book value per share

 

$

2.53

 

 

$

1.13

 

 

$

0.14

 


 

Aeluma, Inc. and Subsidiary
Reconciliation of GAAP and Non-GAAP Financial Measures (unaudited)

 

 

 

Three Months Ended

 

($ in thousands, except per share data)

 

September 30,
2025

 

 

June 30,
2025

 

 

September 30,
2024

 

GAAP net loss

 

$

(1,493

)

 

$

(859

)

 

$

(730

)

Non-GAAP adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

1,056

 

 

 

744

 

 

 

167

 

Consulting and advisory - restricted stock award

 

 

-

 

 

 

3

 

 

 

7

 

Amortization of discount on convertible notes

 

 

-

 

 

 

-

 

 

 

145

 

Changes in fair value of derivative liabilities

 

 

-

 

 

 

-

 

 

 

(146

)

Total adjustments to GAAP net loss

 

 

1,056

 

 

 

747

 

 

 

173

 

Non-GAAP net loss

 

$

(437

)

 

$

(112

)

 

$

(557

)

Depreciation & amortization

 

 

102

 

 

 

109

 

 

 

100

 

Interest income

 

 

(115

)

 

 

(110

)

 

 

-

 

Adjusted EBITDA

 

$

(450

)

 

$

(113

)

 

$

(457

)

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net loss per share – basic and diluted

 

$

(0.09

)

 

$

(0.05

)

 

$

(0.06

)

Non-GAAP adjustments

 

 

0.06

 

 

 

0.04

 

 

 

0.02

 

Non-GAAP net loss per share – basic and diluted

 

$

(0.03

)

 

$

(0.01

)

 

$

(0.04

)



 

Aeluma, Inc. and Subsidiary
Consolidated Statements of Cash Flows (unaudited)

 

 

 

Three Months Ended
September 30,

 

($ in thousands)

 

2025

 

 

2024

 

Operating activities:

 

 

 

 

 

 

Net loss

 

$

(1,493

)

 

$

(730

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Amortization of deferred compensation

 

 

-

 

 

 

7

 

Stock-based compensation expense

 

 

1,056

 

 

 

167

 

Depreciation and amortization expense

 

 

102

 

 

 

100

 

Amortization of discount on convertible notes

 

 

-

 

 

 

145

 

Changes in fair value of derivative liabilities

 

 

-

 

 

 

(146

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(286

)

 

 

(262

)

Prepaids and other current assets

 

 

(196

)

 

 

(167

)

Other assets

 

 

(8

)

 

 

 

-

Accounts payable

 

 

(88

)

 

 

(79

)

Accrued expenses and other current liabilities

 

 

98

 

 

 

34

 

Net cash used in operating activities

 

 

(815

)

 

 

(931

)

Investing activities:

 

 

 

 

 

 

 

 

Purchase of equipment

 

 

(210

)

 

 

(2

)

Net cash used in investing activities

 

 

(210

)

 

 

(2

)

Financing activities:

 

 

 

 

 

 

 

 

Proceeds from stock option exercise

 

 

47

 

 

 

-

 

Proceeds from convertible notes issuance

 

 

-

 

 

 

3,145

 

Proceeds from public offering, net of offering costs

 

 

23,385

 

 

 

-

 

Net cash provided by financing activities

 

 

23,432

 

 

 

3,145

 

Net change in cash and cash equivalents, and certificate of deposit

 

 

22,407

 

 

 

2,212

 

Cash and cash equivalents, and certificate of deposit, beginning of period

 

 

15,740

 

 

 

1,291

 

Cash and cash equivalents, and certificate of deposit, end of period

 

$

38,147

 

 

$

3,503

 

 

 

 

 

 

 

 

 

 

Supplemental non-cash disclosures:

 

 

 

 

 

 

 

 

Right of use asset - operating obtained in exchange for lease liability - operating

 

$

274

 

 

 

-